This is an old revision of the document!


AstraZeneca

COVID-19

AstraZeneca is distributing a viral vector-based COVID-19 vaccine product in Canada and other countries. It is marketed in Canada as Vaxzevria.1)

Affiliations

AstraZeneca is a member organization of the World Economic Forum.2)

Acquisitions

AstraZeneca acquired Alexion in 2021, adding its rare disease brand to the company's portfolio.3)

1)
Health Canada. (2021, November 23). AstraZeneca Vaxzevria COVID-19 vaccine. Government of Canada. Retrieved December 5, 2021, from https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca.html
2)
AstraZeneca. (2021, December 3). World Economic Forum. https://archive.ph/CV1XD
3)
Kemp, A. (2021, July 21). Acquisition of Alexion completed. AstraZeneca. https://archive.ph/c5apv
Back to top